These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1673722)

  • 1. Response to sulfasalazine in rheumatoid arthritis: life table analysis of a 5-year followup.
    Jones E; Jones JV; Woodbury JF
    J Rheumatol; 1991 Feb; 18(2):195-8. PubMed ID: 1673722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapeutic maintenance and tolerance of sulfasalazine in rheumatoid polyarthritis. Retrospective study of 95 patients].
    Pertuiset E; Lioté F; Chevret S; Bardin T; Dryll A; Kuntz D
    Rev Rhum Mal Osteoartic; 1992 Oct; 59(9):545-52. PubMed ID: 1363000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sulfasalazine: side effects and duration of therapy in patients with rheumatoid arthritis].
    Mundo A; Pedone V; Lamanna G; Cervini C
    Clin Ter; 1997; 148(1-2):7-13. PubMed ID: 9377840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intention-to-treat analysis of 200 patients with rheumatoid arthritis 12 years after random allocation to either sulfasalazine or penicillamine.
    Capell HA; Maiden N; Madhok R; Hampson R; Thomson EA
    J Rheumatol; 1998 Oct; 25(10):1880-6. PubMed ID: 9779839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Methotrexate and salazosulfapyridine in the long-term treatment of rheumatoid arthritis].
    Ichikawa Y; Shinozawa T; Yoshida T; Kameda H; Suzuki Y; Kawai S; Yamada H; Matsuda T
    Ryumachi; 1995 Aug; 35(4):663-70. PubMed ID: 7482063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sulfasalazine in the treatment of rheumatoid arthritis. A multicenter open study of 150 patients during 6 months].
    Rev Rhum Mal Osteoartic; 1992 Nov; 59(11):707-13. PubMed ID: 1363986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A one-year, open, prospective study of sulfasalazine in the treatment of rheumatoid arthritis: adverse reactions and clinical response in relation to laboratory variables, drug and metabolite serum levels, and acetylator status.
    Chalmers IM; Sitar DS; Hunter T
    J Rheumatol; 1990 Jun; 17(6):764-70. PubMed ID: 1974926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longterm methotrexate use in rheumatoid arthritis: 12 year followup of 460 patients treated in community practice.
    Wluka A; Buchbinder R; Mylvaganam A; Hall S; Harkness A; Lewis D; Littlejohn GO; Miller MH; Ryan PF
    J Rheumatol; 2000 Aug; 27(8):1864-71. PubMed ID: 10955325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Results of a clinical trial of sulfasalazine in rheumatoid arthritis].
    Pelísková Z; Trnavský K; Gatterová J; Macek J
    Vnitr Lek; 1989 Jan; 35(1):62-7. PubMed ID: 2564708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term usage and side-effect profile of sulphasalazine in rheumatoid arthritis.
    van Riel PL; van Gestel AM; van de Putte LB
    Br J Rheumatol; 1995 Nov; 34 Suppl 2():40-2. PubMed ID: 8535648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulphasalazine therapy in rheumatoid arthritis. A two-year study and follow-up of clinical results.
    Georgescu C
    Rom J Intern Med; 1992; 30(2):127-32. PubMed ID: 1353901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulfasalazine therapy for juvenile rheumatoid arthritis.
    Imundo LF; Jacobs JC
    J Rheumatol; 1996 Feb; 23(2):360-6. PubMed ID: 8882047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved functional ability in patients with rheumatoid arthritis--longterm treatment with leflunomide versus sulfasalazine. European Leflunomide Study Group.
    Kalden JR; Scott DL; Smolen JS; Schattenkirchner M; Rozman B; Williams BD; Kvien TK; Jones P; Williams RB; Oed C; Rosenburg R;
    J Rheumatol; 2001 Sep; 28(9):1983-91. PubMed ID: 11550964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulphasalazine in the treatment of rheumatoid arthritis.
    Pelísková Z; Vácha J; Trnavský K
    Z Rheumatol; 1985; 44(6):263-6. PubMed ID: 2869625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulfasalazine has a better efficacy/toxicity profile than auranofin--evidence from a 5 year prospective, randomized trial.
    McEntegart A; Porter D; Capell HA; Thomson EA
    J Rheumatol; 1996 Nov; 23(11):1887-90. PubMed ID: 8923361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Salazosulfapyridine in rheumatoid arthritis. A study of 49 patients].
    Hilliquin P; Munoz A; Menkes CJ
    Ann Med Interne (Paris); 1992; 143(3):149-54. PubMed ID: 1355956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sulfasalazine in rheumatoid arthritis].
    Segal R; Caspi D; Sukenik S; Horowitz I; Rubinov A; Fluser D; Scharf Y; Shapira D; Weinberger A; Gedz D
    Harefuah; 1991 May; 120(10):577-81. PubMed ID: 1682225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmachem's salazopyrine in rheumatoid arthritis].
    Konstantinova M; Konstantinova V
    Vutr Boles; 1990; 29(5):65-8. PubMed ID: 1981958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulfasalazine in severe rheumatoid arthritis: a study to assess potential correlates of efficacy and toxicity.
    Martin L; Sitar DS; Chalmers IM; Hunter T
    J Rheumatol; 1985 Apr; 12(2):270-3. PubMed ID: 2863375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sulfasalazine (Azulfidine RA) versus aurothioglucose in therapy of chronic polyarthritis--status report of an open, comparative, multicenter long-term study].
    Schattenkirchner M
    Z Rheumatol; 1987; 46(2):67-70. PubMed ID: 2885986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.